Statistics
Publications
1
Citations
138
H-Index
1
Active since
2023
Affiliations
Virginia Tech(Current)
Zachary Hubshman is an author at Virginia Tech specializing in glucagon-like peptide-1 receptor agonists, weight loss, and incretin-based therapies.
Publications per year
2023–2023
1
1
Semaglutide and Tirzepatide reduce alcohol consumption in individuals with obesity
Fatima Quddos, Zachary Hubshman, Allison N. Tegge et al. · Scientific Reports · 2023 · 138 citations · Full text
1–1 of 1